Multidrug-resistant hypervirulent Klebsiella pneumoniae: an evolving superbug

Related Experiment Video

Updated: May 20, 2025

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

12.6K

Yu Zheng1, Xiaojue Zhu1, Chao Ding1

  • 1Department of Clinical Laboratory, The Affiliated Zhangjiagang Hospital of Soochow University, Suzhou, China.

Future Microbiology
|March 26, 2025
PubMed

Insights

Multidrug-resistant hypervirulent Klebsiella pneumoniae (MDR-hvKP) is a dangerous superbug combining high virulence and antibiotic resistance. Understanding MDR-hvKP

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Multidrug-resistant hypervirulent Klebsiella pneumoniae (MDR-hvKP) strains are emerging, challenging the notion that hypervirulent Klebsiella pneumoniae (hvKP) are antibiotic-sensitive.
  • These MDR-hvKP infections have been reported primarily in Asia, notably China.
  • Classical Klebsiella pneumoniae (cKP) strains, known for efficient gene uptake, may more readily transform into MDR-hvKP.

Purpose of the Study:

  • To review the key biological aspects of MDR-hvKP.
  • To elucidate virulence factors, resistance mechanisms, and formation pathways of MDR-hvKP.
  • To discuss methods for identifying MDR-hvKP.

Main Methods:

  • Literature review of existing studies on MDR-hvKP.
  • Analysis of virulence factors and resistance mechanisms.
  • Discussion of genetic transformation and identification strategies.

Main Results:

  • MDR-hvKP represents a significant public health threat due to its dual characteristics.
  • hvKP strains can acquire resistance genes, but transformation from cKP appears a common pathway.
  • Identification and understanding of MDR-hvKP biology are crucial.

Conclusions:

  • MDR-hvKP strains pose a severe threat due to their combined pathogenicity and multidrug resistance.
  • Continued surveillance and enhanced control measures are essential to manage the spread and impact of MDR-hvKP.
  • Further research into the biology and control of MDR-hvKP is warranted.
Keywords:
Klebsiella pneumoniaediagnostic microbiologyhorizontal gene transfermultidrug resistancevirulence factor

More Related Videos

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants15:49

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants

Published on: June 9, 2022

1.2K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

108

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
52.1K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.5K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.7K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
212